Caproni M, Verdelli A. An update on the nomenclature for cutaneous vasculitis. Curr Opin Rheumatol. 2019;31(1):46–52. https://doi.org/10.1097/BOR.0000000000000563.

Article  PubMed  Google Scholar 

Arora A, Wetter DA, Gonzalez-Santiago TM, Davis MDP, Lohse CM. Incidence of leukocytoclastic vasculitis, 1996 to 2010: A population-based study in olmsted county, minnesota. Mayo Clin Proc. 2014;89(11):1515–24. https://doi.org/10.1016/j.mayocp.2014.04.015.

Article  PubMed  Google Scholar 

Fraticelli P, Benfaremo D, Gabrielli A. Diagnosis and management of leukocytoclastic vasculitis. Intern Emerg Med. 2021;16(4):831–41. https://doi.org/10.1007/s11739-021-02688-x.

Article  PubMed  PubMed Central  Google Scholar 

Martinez-Taboada VM, Blanco R, Garcia-Fuentes M, Rodriguez-Valverde V. Clinical features and outcome of 95 patients with hypersensitivity vasculitis. Am J Med. 1997;102(2):186–91. https://doi.org/10.1016/S0002-9343(96)00405-6.

Article  CAS  PubMed  Google Scholar 

Felix-Getzik E, Sylvia LM. Vancomycin-induced leukocytoclastic vasculitis. Pharmacotherapy. 2009;29(7):846–51. https://doi.org/10.1592/phco.29.7.846.

Article  PubMed  Google Scholar 

Sharma P, Sharma E, Neupane SP, Dahal S, Dahal S. Vancomycin-Induced Leukocytoclastic Vasculitis: A Rare Case Report. J Investig Med High Impact Case Reports. 2018;6. https://doi.org/10.1177/2324709618820873

Heijnen EBJ, Bentala M, Van Der Meer NJM. Purpura in a patient receiving vancomycin: A leukoclastic vasculitis? J Cardiothorac Vasc Anesth. 2011;25(2):390–1. https://doi.org/10.1053/j.jvca.2010.02.027.

Article  PubMed  Google Scholar 

Misra D, Patro P, Sharma A. Drug-induced vasculitis. Indian J Rheumatol. 2019;14(5):S3–9. https://doi.org/10.4103/0973-3698.272156.

Article  Google Scholar 

Yaseen K, Nevares A, Tamaki H. A Spotlight on Drug-Induced Vasculitis. Curr Rheumatol Rep. 2022;24(11):323–36. https://doi.org/10.1007/s11926-022-01088-0.

Article  PubMed  Google Scholar 

Drouet M, Chai F, Barthélémy C, Lebuffe G, Debaene B, Décaudin B, et al. Endothelial cell toxicity of vancomycin infusion combined with other antibiotics. Antimicrob Agents Chemother. 2015;59(8):4901–6. https://doi.org/10.1128/AAC.00612-15.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45. https://doi.org/10.1038/clpt.1981.154.

Article  CAS  PubMed  Google Scholar 

Singh I, Gidda H, Nashed B. Vancomycin-Induced Leukocytoclastic Vasculitis: A Rare Complication From a Commonly Used Medication. Cureus Published online. 2023. https://doi.org/10.7759/cureus.36532.

Article  Google Scholar 

42 Vancomycin-Related Leukocytoclastic Vasculitis With Worsening AKI. Am J Kidney Dis. 2023;81(4):S12-S13https://doi.org/10.1053/j.ajkd.2023.01.044

Pingili CS, Okon EE. Vancomycin-induced leukocytoclastic vasculitis and acute renal failure due to tubulointerstitial nephritis. Am J Case Rep. 2017;18:1024–7. https://doi.org/10.12659/AJCR.905214.

Article  PubMed  PubMed Central  Google Scholar 

Dapaah-Afriyie K. Vancomycin-induced vasculitis. In: Hospital Medicine 2011: Research, Innovations, Clinical Vignettes Competition. Grapevine, TX: Gaylord Texan Resort and Convention Center; 2011 May 10–13. Presented at: 2011

Pongruangporn M, Ritchie DJ, Lu D, Marschall J. Vancomycin-Associated Leukocytoclastic Vasculitis. Case Rep Infect Dis. 2011;2011:1–3. https://doi.org/10.1155/2011/356370.

Article  Google Scholar 

Russell JP, Weenig RH. Primary cutaneous small vessel vasculitis. Curr Treat Options Cardiovasc Med. 2004;6(2):139–49. https://doi.org/10.1007/s11936-004-0042-3.

Article  PubMed  Google Scholar 

Jachiet M, Flageul B, Deroux A, Le Quellec A, Maurier F, Cordoliani F, et al. The clinical spectrum and therapeutic management of hypocomplementemic urticarial vasculitis: Data from a french nationwide study of fifty-seven patients. Arthritis Rheumatol. 2015;67(2):527–34. https://doi.org/10.1002/art.38956.

Article  CAS  PubMed  Google Scholar 

Cury DB, De Souza AWS, Vianna GA, Odashiro D, Farias A, Moss AC. Cutaneous vasculitis in a patient with Crohn’s disease treated with adalimumab. Inflamm Bowel Dis. 2017;23(1):E1–2. https://doi.org/10.1097/MIB.0000000000000982.

Article  PubMed  Google Scholar 

Russell JP, Gibson LE. Primary cutaneous small vessel vasculitis: Approach to diagnosis and treatment. Int J Dermatol. 2006;45(1):3–13. https://doi.org/10.1111/j.1365-4632.2005.02898.x.

Article  PubMed  Google Scholar 

Brown NM, Brown NM, Goodman AL, Horner C, Jenkins A, Brown EM. Treatment of methicillin-resistant Staphylococcus aureus (MRSA): Updated guidelines from the UK. J Antimicrob Chemother. 2021;76(6):1377–8. https://doi.org/10.1093/jac/dkab036.

Article  CAS  PubMed  Google Scholar 

Davidovici BB, Wolf R. The challenge of drug-rechallenge: Facts and controversies. Clin Dermatol. 2010;28(3):349–53. https://doi.org/10.1016/j.clindermatol.2009.06.019.

Article  PubMed  Google Scholar